Pin­cer move­ment: Cal­i­for­nia biotech gets $35M to suf­fo­cate can­cer in co­or­di­nat­ed at­tack

Hav­ing served in Afghanistan, the navy vet­er­an lead­ing Cal­i­for­nia-based Epi­cen­tRx wants to leave no pa­tient be­hind with his ar­se­nal of an­ti-can­cer drugs. On Thurs­day, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER